Stories
HBA names Celia Gonser among 2023 Rising Stars
June 2, 2023
The Healthcare Businesswoman’s Association (HBA) recognized Magellan Rx’s Director of Strategic Sales Partnership Celia Gonser as one of its 2023 Rising Stars.
HBA Rising Stars are professionals in various sectors of the health care industry, including pharmaceutical, biotechnology, advertising, public relations, medical education, and market research, among other fields. Nominated by the HBA’s Corporate Partners, the Rising Stars represent various career stages and disciplines and have demonstrated noteworthy achievements and proven attention to furthering their careers.
“I’m honored to be counted among this year’s esteemed group of Rising Stars,” said Celia. “It’s gratifying to be recognized for my career achievements, and I look forward to staying engaged with HBA to further the advancement and impact of women working in the health care industry.”
The 2023 Rising Stars were honored at the 2023 HBA Woman of the Year event on May 16. To see the full listing of 2023 Rising Stars and learn more about HBA’s mission, vision and purpose, visit hbanet.org.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion